SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063354
Filing Date
2023-11-14
Accepted
2023-11-14 07:35:45
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrt-20230930.htm   iXBRL 10-Q 2084550
2 EX-10.1 tcrt-ex10_1.htm EX-10.1 78814
3 EX-10.2 tcrt-ex10_2.htm EX-10.2 78808
4 EX-31.1 tcrt-ex31_1.htm EX-31.1 14435
5 EX-32.1 tcrt-ex32_1.htm EX-32.1 7441
6 GRAPHIC img41163667_0.jpg GRAPHIC 22194
7 GRAPHIC img42087188_0.jpg GRAPHIC 22194
8 GRAPHIC img160813313_0.jpg GRAPHIC 15323
  Complete submission text file 0000950170-23-063354.txt   7322025

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrt-20230930_cal.xml EX-101.CAL 29950
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrt-20230930_pre.xml EX-101.PRE 381420
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrt-20230930_lab.xml EX-101.LAB 484292
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrt-20230930_def.xml EX-101.DEF 293314
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrt-20230930.xsd EX-101.SCH 60522
58 EXTRACTED XBRL INSTANCE DOCUMENT tcrt-20230930_htm.xml XML 825191
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 231401599
SIC: 2834 Pharmaceutical Preparations